Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02144870
Other study ID # THICS-Study
Secondary ID
Status Recruiting
Phase N/A
First received April 14, 2014
Last updated March 14, 2017
Start date November 2013
Est. completion date September 2017

Study information

Verified date March 2017
Source University of Cologne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main purpose of this study is to evaluate the efficacy of a habit reversal based treatment programme compared to an alternative treatment which aims at the activation of resources in children and adolescents aged 8 to 18 years with tic disorders.


Description:

The main purpose of this study is to evaluate the efficacy of a habit reversal based treatment programme (THICS, Woitecki & Döpfner, 2014) compared to an intervention aimed at the activation of resources (STARK, Perri et al., 2014) for children and adolescents with tic disorders. This habit reversal treatment programme was developed at the Department of Child and Adolescent Psychiatry and Psychotherapy at the University of Cologne and has already been evaluated in a pilot-study (Woitecki & Döpfner, 2011, 2012). The activation of resources treatment programme was also developed at this Department and is currently evaluated in different studies. Effects are expected in both interventions, but a larger effect is expected in the THICS treatment


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date September 2017
Est. primary completion date July 2017
Accepts healthy volunteers No
Gender All
Age group 8 Years to 18 Years
Eligibility Inclusion Criteria:

- 8-18 years

- Diagnosis of chronic motor or vocal Tic (F95.1) or Tourette-Syndrome (F95.2)

- YGTSS total score F95.2>13, F95.1>9

- Tics are the main problems

- Intelligence IQ>80

- If medication, then has been stable for at least one months in medicated patients

- No change in medication treatment is planned

- Ability to participate in weekly outpatient treatment

- Acceptance of randomization

Exclusion Criteria:

Diagnosis of Autism Spectrum Disorder or Psychosis Parallel continuous psychotherapy of tics or comorbid -

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Habit Reversal Training
awareness training, competing response training
Resources activation


Locations

Country Name City State
Germany University Hospital of Cologne, Department of Childhood and Adolescent Psychiatry and Psychotherapy Cologne

Sponsors (1)

Lead Sponsor Collaborator
University of Cologne

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in Symptom Checklist for Tic-Symptoms (FBB-TIC, parent rating) at week 8, 16 and 24 The FBB-TIC is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by parents eight weeks (T1), sixteen weeks (T2) and 24 weeks (T3)
Primary Change in Quality of Life (Tic-HRQoL-FBB)(parent rating) The Tic-HRQoL-FBB is used to assess impairment and quality of life through tic symptoms and other comorbid symptoms rated by parents eight weeks (T1) and twenty-four weeks (T3)
Secondary Change in Symptom Checklist for Tic-Symptoms (FBB-/SBB-TIC), Teacher-/self-rating The SBB-TIC is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by parents eight weeks (T1), sixteen weeks (T2) and 24 weeks (T3)
Secondary Change in Symptom Checklist for Tic-Symptoms, clinical rating The Checklist is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by clinicians eight weeks (T1), sixteen weeks (T2) and 24 weeks (T3)
Secondary Change of comorbid ADHD Symptoms (FBB/SBB-ADHD), parent, teacher and self-rating The Symptom Checklist for Attention Deficit/Hyperactivity Disorder (FBB-/SBB-ADHS) assess all symptom criteria according to DSM IV and ICD-10. eight weeks (T1), and 24 weeks (T3)
Secondary Change of comorbid OCD Symptoms (ZWIK-E), parent-rating The ZWIK assess OCD criteria. eight weeks (T1), and 24 weeks (T3)
Secondary Change of comorbid Symptoms (CBCL/TRF/YSR), parent-/teacher-/self-rating The CBCL, TRF and YSR assess a variation of different criteria. eight weeks (T1), and 24 weeks (T3)
Secondary Change in self-esteem (Harter-Scale-SBB)(self rating) The Harter-Scale is used to assess self-esteem eight weeks (T1), and 24 weeks (T3)
Secondary Change in Tic-Symptoms (YGTSS-TIC), overall score The YGTSS is used to assess Tic-Symptoms in a semi structured interview with parents and patients eight weeks (T1), sixteen weeks (T2) and 24 weeks (T3)
Secondary Change in Tic-Symptoms (observation) Tic symptoms are observed through video tapes and are rated through clinicians. 24 weeks (weekly assessment)
See also
  Status Clinical Trial Phase
Recruiting NCT02190383 - Efficacy of a Habit Reversal Treatment on Tic-symptoms N/A
Recruiting NCT02190370 - Efficacy of a Resources Activation Treatment on Tic-symptoms N/A